Literature DB >> 21528353

Genetic variants of 6q25 and breast cancer susceptibility: a two-stage fine mapping study in a Chinese population.

Jing Han1, Tao Jiang, Hongling Bai, Hongru Gu, Jing Dong, Hongxia Ma, Zhibin Hu, Hongbing Shen.   

Abstract

A recent genome-wide association study identified a novel single nucleotide polymorphism (SNP), rs2046210, in the 6q25 region as a breast cancer susceptibility locus in Chinese and subsequently replicated in a multicenter study. Further fine-mapping of this region may help identify the potential causative SNPs of breast cancer. We employed a block-based fine mapping analysis to investigate the tagging SNPs in a 41 kb block with the marker-SNP rs2046210 in the 6q25 region, and also extended our study by including two potentially functional SNPs (rs2234693 and rs1801132) within the ESR1 gene by a two-stage case-control study with 1,792 breast cancer cases and 1,867 controls (878 cases and 900 controls in the testing set and 914 cases and 967 controls in the validation set). Significant associations with breast cancer risk were observed for rs1038304, rs6929137, rs2046210, and rs10484919 in the 41 kb block of the 6q25 region in the testing set after controlling multiple testing. Together with the validation set samples, these four SNPs were all significantly associated with increased risk of breast cancer (additive OR from 1.25 to 1.34, additive P from 4.84 × 10(-6) to 7.17 × 10(-9)). After conditional regression and linkage disequilibrium analyses, rs6929137 and rs10484919 tend to be susceptible markers of breast cancer in this region and both of them were located at sites of histone modification according to the UCSC (http://genome.ucsc.edu/) genome database. Our results support that the 6q25 region is an important susceptibility region for breast cancer in Chinese women, and rs6929137 and rs10484919 are causative or marker SNPs for this region.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528353     DOI: 10.1007/s10549-011-1527-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  14 in total

1.  Genetic variants at 14q24.1 and breast cancer susceptibility: a fine-mapping study in Chinese women.

Authors:  Hongxia Ma; Huizhang Li; Guangfu Jin; Juncheng Dai; Jing Dong; Zhenzhen Qin; Jiaping Chen; Shui Wang; Xinru Wang; Zhibin Hu; Hongbing Shen
Journal:  DNA Cell Biol       Date:  2012-02-07       Impact factor: 3.311

2.  Polymorphisms in the gene encoding estrogen receptor alpha are associated with osteoarthritis in Han Chinese women.

Authors:  Wei Liu; Feng-Min Shao; Lei Yan; Hui-Xia Cao; Dong Qiu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  ESR1 single nucleotide polymorphisms predict breast cancer susceptibility in the central European Caucasian population.

Authors:  Mark F Lipphardt; Mustafa Deryal; Mei Fang Ong; Werner Schmidt; Ulrich Mahlknecht
Journal:  Int J Clin Exp Med       Date:  2013-04-12

4.  Enhanced Identification of Potential Pleiotropic Genetic Variants for Bone Mineral Density and Breast Cancer.

Authors:  Cheng Peng; Hui-Ling Lou; Feng Liu; Jie Shen; Xu Lin; Chun-Ping Zeng; Ji-Rong Long; Kuan-Jui Su; Lan Zhang; Jonathan Greenbaum; Wei-Feng Deng; Yu-Mei Li; Hong-Wen Deng
Journal:  Calcif Tissue Int       Date:  2017-07-31       Impact factor: 4.333

5.  ENPP1 and ESR1 genotypes influence temporomandibular disorders development and surgical treatment response in dentofacial deformities.

Authors:  Romain Nicot; Alexandre R Vieira; Gwénaël Raoul; Constance Delmotte; Alain Duhamel; Joël Ferri; James J Sciote
Journal:  J Craniomaxillofac Surg       Date:  2016-07-21       Impact factor: 2.078

6.  Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.

Authors:  Juncheng Dai; Zhibin Hu; Yue Jiang; Hao Shen; Jing Dong; Hongxia Ma; Hongbing Shen
Journal:  Breast Cancer Res       Date:  2012-01-23       Impact factor: 6.466

7.  A common polymorphism near the ESR1 gene is associated with risk of breast cancer: evidence from a case-control study and a meta-analysis.

Authors:  Hui Guo; Jie Ming; Chunping Liu; Zhi Li; Ning Zhang; Hongtao Cheng; Wei Wang; Wei Shi; Na Shen; Qunzi Zhao; Dapeng Li; Pengfei Yi; Longqiang Wang; Rui Wang; Yue Xin; Xiangwang Zhao; Xiu Nie; Tao Huang
Journal:  PLoS One       Date:  2012-12-18       Impact factor: 3.240

8.  Association Between ESR1 PvuII, XbaI, and P325P Polymorphisms and Breast Cancer Susceptibility: A Meta-Analysis.

Authors:  Yiming Zhang; Ming Zhang; Xiaosong Yuan; Zhichen Zhang; Ping Zhang; Haojie Chao; Lixia Jiang; Jian Jiang
Journal:  Med Sci Monit       Date:  2015-10-04

9.  Hereditary breast cancer: ever more pieces to the polygenic puzzle.

Authors:  Natalia Bogdanova; Sonja Helbig; Thilo Dörk
Journal:  Hered Cancer Clin Pract       Date:  2013-09-11       Impact factor: 2.857

10.  Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.

Authors:  Yanru Wang; Yisha He; Zhenzhen Qin; Yue Jiang; Guangfu Jin; Hongxia Ma; Juncheng Dai; Jiaping Chen; Zhibin Hu; Xiaoxiang Guan; Hongbing Shen
Journal:  Breast Cancer Res       Date:  2014-08-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.